Patent ID: 8211860

Claim:
A method of inhibiting infection of the cells by human immunodeficiency virus comprising topically administering to a subject at risk of infection by human immunodeficiency virus a construct of the formula F-S1-S2-L where F is 1-O—(O-α-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl, S1 is 2-aminoethyl, 3-aminopropyl, 4-aminobutyl or 5-aminopentyl, S2 is —CO(CH 2 ) 3 CO—, —CO(CH 2 ) 4 CO or —CO(CH 2 ) 5 CO—, and L is a diacyl- or dialkyl glycerophospholipid.